Fragments of cancer DNA circulating in a patient’s bloodstream could help doctors deliver more personalized treatment for liver cancer, researchers report. The new research may help address a particular challenge posed by liver cancers, which can be difficult to analyze safely, they say.
from Today's Healthcare News -- ScienceDaily http://ift.tt/1RJNWfm
No comments:
Post a Comment